Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients
Clinical trial NCT03905109 · WITHDRAWN
Trial details
- NCT number
- NCT03905109
- Sponsor
- Abivax S.A.
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2022-09-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.